Similarly, NK cells from invasive cancers express lowered NKG2D, and yet, elevated inhibitory receptors (one of which is NKG2A) due to a mechanism modulated by immunosuppressive cytokines (e.g., TGF-β and IDO1) in the TME [117] (Figure 1A,B). Here, KLRK1 is linked to cancer.